Bellevue Biotech DT CHF/ CH0113817123 /
| NAV23/01/2025 | Chg.+61.8599 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,831.9700CHF | +1.64% | reinvestment | Equity Worldwide | Swisscanto Fondsl. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010 | - | - | - | - | - | - | - | - | - | - | -1.66 | 1.39 | - |
| 2011 | 1.41 | -1.76 | 5.63 | 3.67 | -1.02 | -2.43 | -11.13 | -6.21 | 4.23 | 1.33 | 7.19 | 6.20 | +5.58% |
| 2012 | 11.17 | -0.71 | 3.56 | 4.19 | 3.94 | 2.00 | 5.66 | -0.30 | 2.24 | -10.05 | 6.29 | -2.93 | +26.22% |
| 2013 | 6.93 | 4.19 | 9.46 | 8.01 | 8.38 | -5.68 | 13.47 | -3.09 | 5.26 | -2.31 | 8.97 | -1.04 | +64.18% |
| 2014 | 12.55 | 8.16 | -10.84 | -4.52 | 8.16 | 5.41 | 0.92 | 12.17 | 1.41 | 9.42 | 1.53 | 2.18 | +53.98% |
| 2015 | -2.19 | 10.19 | 1.48 | -8.06 | 11.85 | -1.05 | 4.66 | -10.27 | -12.48 | 12.33 | 6.95 | -2.16 | +7.51% |
| 2016 | -23.01 | -9.35 | -0.05 | 4.14 | 7.31 | -11.60 | 11.89 | -1.98 | 1.58 | -12.89 | 12.93 | -4.16 | -27.61% |
| 2017 | 4.69 | 8.65 | -0.31 | 1.37 | -6.69 | 6.50 | 3.68 | 3.71 | -0.10 | -2.98 | -0.83 | 0.33 | +18.45% |
| 2018 | 3.03 | -4.30 | 0.66 | -1.42 | 2.64 | 1.16 | 6.17 | 3.13 | -0.28 | -13.77 | 3.60 | -12.32 | -13.12% |
| 2019 | 13.67 | 4.73 | 1.00 | -4.31 | -5.77 | 5.83 | 0.21 | -3.05 | -2.92 | 5.52 | 12.89 | -1.80 | +26.60% |
| 2020 | -5.22 | -1.56 | -7.73 | 14.32 | 9.59 | 2.36 | -5.17 | 0.04 | 1.43 | -4.14 | 10.27 | 1.57 | +14.04% |
| 2021 | 4.98 | -0.67 | -1.67 | 1.02 | -0.76 | 8.45 | 1.05 | 3.34 | -4.04 | -2.24 | -2.65 | -1.22 | +5.02% |
| 2022 | -10.57 | -4.40 | 5.71 | -3.05 | -3.73 | 1.72 | 3.22 | 0.06 | -0.67 | 8.51 | 1.14 | -6.67 | -9.83% |
| 2023 | 1.52 | -4.86 | -1.21 | -0.61 | 0.37 | -2.53 | -2.69 | 0.66 | -0.93 | -6.90 | -0.26 | 9.36 | -8.57% |
| 2024 | 1.45 | 4.89 | 1.51 | -5.57 | 1.86 | 4.44 | 3.76 | -3.57 | -1.67 | 1.51 | 2.36 | -3.10 | - |
| 2025 | 6.06 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.60% | 19.87% | 18.65% | 20.69% | 23.46% |
| Sharpe ratio | 7.74 | -0.12 | 0.38 | 0.01 | 0.00 |
| Best month | +6.06% | +6.06% | +6.06% | +9.36% | +14.32% |
| Worst month | -3.10% | -3.57% | -5.57% | -10.57% | -10.57% |
| Maximum loss | -2.23% | -9.84% | -11.88% | -23.63% | -34.63% |
| Outperformance | +9.62% | - | +8.65% | +4.48% | -7.28% |
All quotes in CHF
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue Biotech AA CHF | paying dividend | 3,502.9099 | +9.01% | +6.87% | |
| Bellevue Biotech DT CHF | reinvestment | 3,831.9700 | +9.66% | +8.81% | |
| Bellevue Biotech CA CHF | paying dividend | 109.8200 | +9.37% | +7.90% |
Performance
| YTD | +6.06% | ||
|---|---|---|---|
| 6 Months | +0.18% | ||
| 1 Year | +9.66% | ||
| 3 Years | +8.81% | ||
| 5 Years | +13.75% | ||
| Since start | +283.20% | ||
| Year | |||
| 2023 | -8.57% | ||
| 2022 | -9.83% | ||
| 2021 | +5.02% | ||
| 2020 | +14.04% | ||
| 2019 | +26.60% | ||
| 2018 | -13.12% | ||
| 2017 | +18.45% | ||
| 2016 | -27.61% | ||
Dividends
| 17/01/2018 | 0.01 CHF |